drugset / Trial / NCT02667704
Influence of Bosentan on the Pharmacokinetics of Nintedanib
Non-randomizedCrossoverOpen-labelTreatment
Summary
The trial was designed to investigate whether, and to which extent, multiple doses of bosentan may influence the plasma levels of nintedanib administered as a single dose.
Timeline
- Start
- 2016-02
- Primary completion
- 2016-03
- Completion
- 2016-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bosentan | Other / unclassified | — | — |
| Subject | Nintedanib | Small molecule | — | — |
Indications
No indication recorded.